Patents expiring in 2035

US 8945559

Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies

REGENERON PHARMACEUTICALS, INC. · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8945482

System, method and device for tissue-based diagnosis

The Regents of the University of California · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8946158

Treatments of gastrointestinal disorders

IRONWOOD PHARMACEUTICALS, INC. · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8946167

Pharmaceutical compositions containing plasma protein

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8945868

Methods and compositions for modification of a HLA locus

The Board of Regents of the University of Texas System · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8946382

Apelin peptides and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8946165

Compounds for reversing and inhibiting protein aggregation, and methods for making and using them

The Regents of the University of California · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8946415

Pyrazolo[1,5-a]pyrimidine-based compounds, compositions comprising them, and methods of their use

LEXICON PHARMACEUTICALS, INC. · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8945635

Formulations comprising extracts from primitive plant species (mosses, ferns and lichens) to treat and prevent cancers

Southern Connecticut State University · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8945595

Insect repellent and attractants

The Regents of the University of California · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8946176

Compositions and methods for inhibiting expression of RRM2 genes

Arrowhead Research Corporation · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8946424

Deuterated amlexanox

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8945544

Immunogenic compositions comprising progastrin and uses thereof

The Board of Regents of the University of Texas System · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8945602

Porous photonic crystals for drug delivery to the eye

The Regents of the University of California · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8946425

Processes and intermediates for producing azaindoles

Vertex Pharmaceuticals Incorporated · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8946444

Tetrahydrocarbazoles as active agents for inhibiting VEGF production by translational control

PTC THERAPEUTICS, INC. · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8945108

Method of using vasoconstrictive agents during energy-based tissue therapy

Covidien LP · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8946391

Construction of a multivalent scFv through alkyne-azide 1,3-dipolar cycloaddition

The Regents of the University of California · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8945587

Synthetic lipid biology for combinatorial engineering of endotoxin

The Board of Regents of the University of Texas System · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8946291

Compositions and methods for treating pigmentary conditions and melanoma

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8946379

Bladder cancer specific ligand peptides

The Regents of the University of California · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8946233

Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents

Theravance Biopharma R&D IP, LLC · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8946243

Compounds and methods for the treatment of viral infection

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8946285

Oligomer-opioid agonist conjugates

Nektar Therapeutics · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8945508

Dendrimer compositions and methods of synthesis

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8946398

Infectious hepatitis C viruses of genotype 3A and 4A and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8946455

Semi-synthetic small molecules for the treatment parasitic disease

The Regents of the University of California · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8946384

Polypeptide TF1 for inhibiting type 2 Shiga toxin activity, encoding gene for same and use thereof

INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY, ACADEMY OF MILITARY MEDICAL SCIENCES, PR CHINA · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8946194

One-step processing of hydrogels for mechanically robust and chemically desired features

The Board of Regents of the University of Texas System · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8946409

Polycyclic β lactam derivatives for the treatment of cancer

The Board of Regents of the University of Texas System · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8946300

Use of rasagilline for the treatment of restless legs syndrome

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8946271

Water soluble furoxan derivatives having antitumor activity

HUMANITAS MIRASOLE S.P.A. · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8946205

1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors

Addex Pharma, S.A. · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8946172

Method for reducing scarring during wound healing using antisense compounds directed to CTGF

Northwestern University · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8945858

Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory

The Regents of the University of California · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8945604

Ophthalmic device, and method of use thereof, for increasing ocular boundary lubrication

The Regents of the University of California · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8948863

Photokinetic ocular drug delivery methods and apparatus

The Board of Regents of the University of Texas System · Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

WO 2015016729

COMPOSÉS D'URÉE ET LEUR UTILISATION COMME INHIBITEURS DE L'ENZYME FAAH

BIAL PORTELA & Cª S A [PT] · Granted Thu Feb 05 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Jan 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

WO 2015016728

COMPOSÉS D'URÉE ET LEUR UTILISATION COMME INHIBITEURS DE L'ENZYME FAAH

BIAL PORTELA & Cª S A [PT] · Granted Thu Feb 05 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Jan 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2015038439

METHOD FOR PREPARING SUSPENSIONS OF LOW-SOLUBILITY MATERIALS

MACLEOD STEVEN K [US] · Granted Thu Feb 05 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Jan 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 2919844

COMPOSES D'UREE ET LEUR UTILISATION COMME INHIBITEURS DE L'ENZYME FAAH

BIAL PORTELA & CA SA [PT] · Granted Thu Feb 05 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Jan 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8951971

Lymphatic zip codes in tumors and pre-malignant lesions

The Regents of the University of California · Granted Tue Feb 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8952185

Production method of optically active dihydrobenzofuran derivative

Takeda Pharmaceutical Company Limited · Granted Tue Feb 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8952062

Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy

Jazz Pharmaceuticals, Inc. · Granted Tue Feb 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8951972

FGFR1 extracellular domain combination therapies for lung cancer

Five Prime Therapeutics, Inc. · Granted Tue Feb 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8951793

Method of making an isolated population of FOXP3+ regulatory T cells

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8951504

(trimethoxyphenylamino) pyrimidinyl formulations

Rigel Pharmaceuticals, Inc. · Granted Tue Feb 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8951501

Noninvasive thermometry monitoring system

UNITED ARAB EMIRATES UNIVERSITY · Granted Tue Feb 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)